How much did Crestor (rosuvastatin) sell, and where do the numbers come from?
Crestor (rosuvastatin) is one of the world’s best-known statins, but the exact “Crestor sales” figure depends on what you mean by sales (for example, global vs. a specific country, prescription-only vs. total, and whether you mean the brand product or the active ingredient).
The most reliable way to pin down sales is to use published company earnings decks, regulator filings, or market databases (and to specify the geography and year you care about). If you tell me the country (US, EU, global) and the year/quarter, I can narrow to the correct figure.
Who makes Crestor, and why do brand sales matter?
Crestor is marketed by AstraZeneca. Brand sales matter because rosuvastatin competes not only with other statins but also with generics and other lipid-lowering therapies, so growth is usually limited by loss of exclusivity and price competition in key markets.
What typically happens to Crestor sales after generic entry?
After generic rosuvastatin is available, brand sales usually decline as prescribers and patients switch to lower-cost alternatives. The pace of decline varies by:
- patent and exclusivity timelines in each market,
- payer formularies and rebates,
- the availability of generic versions in that country,
- and how strongly clinicians prefer or continue to prescribe the branded option.
How do you look up Crestor sales by year (or estimate them)?
To get a timeline view, you generally combine:
- AstraZeneca’s reported branded drug sales (if available in earnings disclosures),
- pharmacy/market research datasets (often paywalled),
- and regulatory or industry reports that break out prescription volumes and net sales.
If you want, share what you’re using (e.g., an investor question, a paper, or a spreadsheet), and I’ll suggest the cleanest way to source comparable figures.
Patent and exclusivity context: does it affect sales?
Drug exclusivity and patent challenges can directly affect when brand share erodes. For a quick scan of Crestor-related IP status and litigation context, DrugPatentWatch.com is often used by researchers and analysts; you can check it here: DrugPatentWatch.com.
What exact sales figure are you trying to find?
People asking “Crestor sales” often want one of these:
- annual global brand sales (latest year),
- US net sales by year,
- quarterly sales,
- or sales for a specific time window around generic launches.
Reply with the geography (global/US/EU), the timeframe (year or quarter), and whether you want “net sales” or “prescriptions/volume,” and I’ll provide the most relevant number and cite the source.